Impact of letrozole-associated controlled ovarian hyperstimulation on ART outcomes and endocrinological parameters

Hum Reprod. 2022 Oct 31;37(11):2722-2723. doi: 10.1093/humrep/deac206.

Authors

Oranite Goldrat¹, Anne Delbaere¹, Isabelle Demeestere²

Affiliations

¹ Fertility Clinic, Department of Obstetrics and Gynecology, CUB Erasme hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium.
² Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium.

PMID: 36124889
DOI: 10.1093/humrep/deac206

No abstract available

Publication types

Comment

MeSH terms

Female
Humans
Letrozole
Ovarian Hyperstimulation Syndrome*
Ovulation Induction

Substances

Letrozole